Annual Total Liabilities
$19.05 M
+$641.00 K+3.48%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual total liabilities is $19.05 million, with the most recent change of +$641.00 thousand (+3.48%) on December 31, 2023.
- During the last 3 years, NRXP annual total liabilities has fallen by -$27.66 million (-59.22%).
- NRXP annual total liabilities is now -59.22% below its all-time high of $46.71 million, reached on December 31, 2020.
Performance
NRXP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$23.28 M
-$371.00 K-1.57%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly total liabilities is $23.28 million, with the most recent change of -$371.00 thousand (-1.57%) on September 30, 2024.
- Over the past year, NRXP quarterly total liabilities has increased by +$4.43 million (+23.48%).
- NRXP quarterly total liabilities is now -50.15% below its all-time high of $46.71 million, reached on December 31, 2020.
Performance
NRXP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NRXP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.5% | +23.5% |
| 3 y3 years | -59.2% | +189.5% |
| 5 y5 years | -59.2% | - |
NRXP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.8% | -1.6% | +228.8% |
| 5 y | 5-year | -59.2% | +59.8% | -50.1% | +228.8% |
| alltime | all time | -59.2% | +59.8% | -50.1% | +228.8% |
NRx Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $23.28 M(-1.6%) |
| Jun 2024 | - | $23.66 M(+25.4%) |
| Mar 2024 | - | $18.86 M(-1.0%) |
| Dec 2023 | $19.05 M(+3.5%) | $19.05 M(-1.4%) |
| Sep 2023 | - | $19.33 M(-14.5%) |
| Jun 2023 | - | $22.62 M(+2.5%) |
| Mar 2023 | - | $22.06 M(+19.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $18.41 M(+54.4%) | $18.41 M(+128.9%) |
| Sep 2022 | - | $8.04 M(+13.6%) |
| Jun 2022 | - | $7.08 M(-40.6%) |
| Mar 2022 | - | $11.91 M(-0.1%) |
| Dec 2021 | $11.92 M(-74.5%) | $11.92 M(-67.1%) |
| Sep 2021 | - | $36.28 M(+0.8%) |
| Jun 2021 | - | $35.98 M(-23.0%) |
| Dec 2020 | $46.71 M | $46.71 M |
FAQ
- What is NRx Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual total liabilities year-on-year change?
- What is NRx Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly total liabilities year-on-year change?
What is NRx Pharmaceuticals annual total liabilities?
The current annual total liabilities of NRXP is $19.05 M
What is the all time high annual total liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual total liabilities is $46.71 M
What is NRx Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, NRXP annual total liabilities has changed by +$641.00 K (+3.48%)
What is NRx Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of NRXP is $23.28 M
What is the all time high quarterly total liabilities for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly total liabilities is $46.71 M
What is NRx Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, NRXP quarterly total liabilities has changed by +$4.43 M (+23.48%)